WADE BAYLESS: Open Payments
NPI 1932795259 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 37 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $763 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $482 |
| Vanda Pharmaceuticals Inc. | 8 | $344 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $111 |
| E.R. Squibb & Sons, L.L.C. | 4 | $104 |
| Indivior Inc. | 2 | $54 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: VRAYLAR, FANAPT, CAPLYTA, COBENFY, SUBLOCADE, Qelbree, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
